Nicholas D. James, MB, PhD, on Bladder Cancer: MRI and Biopsy vs Resection for Cystoscopic Staging

Posted: Thursday, September 15, 2022

Nicholas D. James, MB, PhD, of London’s Institute of Cancer Research, discusses initial results from BladderPath, a study that compared MRI and biopsy vs surgical resection for diagnosis and staging of suspected muscle-invasive bladder cancer. The findings suggest that use of the image-guided pathway may halve the time to treatment with no apparent adverse effect on outcomes for patients with non–muscle-invasive disease.